WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Nov. 4, 2024, from the American Association for Community Psychiatry and 14 collaborators: * * * To: Dr. Vincent Lo Re III, MD, MSCE Chair Drug Risk Management Advisory Committee Center for Drug Evaluation & Research U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 * Dr. Rajesh Narendran, MD C  more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Oct. 30, 2024, from Harun Abdur Rahman, co-founder of CureSCG, Denver, Colorado: * * * To: Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research * To: Patrizia Cavazzoni, MD Director Center for Drug Evaluation and Research U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Springs, MD 20993 * * *  more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Oct. 24, 2024, from Adrienne McBride, executive director at the FD/MAS Alliance, Bethesda, Maryland: * * * To: Patrizia Cavazzoni, M.D. Director, Center for Drug Evaluation and Research U.S. Food and Drug Administration 10001 New Hampshire Ave Silver Spring, MD 20903 * To: Peter Marks, M.D. Director, Center for Biologics Evaluation and  more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Oct. 30, 2024, from Rachel DeConti, executive director of the LGMD2D Foundation, San Francisco, California: * * * To: Patrizia Cavazzoni, MD Director, Center for Drug Evaluation and Research * To: Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research U.S. Food and Drug Administration 10903 New Hampshire Avenue Sil  more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Oct. 29, 2024, from the Hal Tily, vice president of research and development at the LGMD2L Foundation: * * * Public comment on FDA-2024-N-3528 for "Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub; Public Meeting; Request for Comments." To: Patrizia Cavazzoni, MD Director, Center for Drug Evaluation and Research   more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication on Oct. 31, 2024, from Praxis Precision Medicines, Boston, Massachusetts: * * * To: Janet Goldberg Center for Biologics Evaluation and Research 10903 New Hampshire Ave. Bldg. 71, Rm. 7301 Silver Spring, MD 20993-0002 * To: Cynthia Rothblum-Oviatt Center for Drug Evaluation and Research 10903 New Hampshire Ave. Bldg. 22, Rm. 5390 Silver Sp  more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication on Oct. 21, 2024, from Praxis Precision Medicines, Boston, Massachusetts: * * * To: Janet Goldberg Center for Biologics Evaluation and Research 10903 New Hampshire Ave. Bldg. 71, Rm. 7301 Silver Spring, MD 20993-0002 * To: Cynthia Rothblum-Oviatt Center for Drug Evaluation and Research 10903 New Hampshire Ave. Bldg. 22, Rm. 5390 Silver Sp  more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Oct. 31, 2024, from the Rare Disease Company Coalition: * * * To: Director Peter Marks, M.D., Ph.D. Center for Biologics Evaluation and Research (CBER) 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002 * To: Director Patrizia Cavazzoni, M.D. Center for Drug Evaluation and Research (CDER) 10001 New Hampshire Ave, Silver Spring,   more

WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services Food and Drug Administration has released the following public communication dated Oct. 30, 2024, from Jessica Myers, communications and advocacy manager at the U.S. Hereditary Angioedema Association: * * * To: Janet Goldberg Center for Biologics Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 71, Rm. 7301 Silver Spring, MD 20993-0002 * To: Cynthia Rothblum-Oviatt Center for Drug   more

CONCORD, New Hampshire, Nov. 2 -- The New Hampshire Department of Insurance issued the following news release on Nov. 1, 2024: The New Hampshire Insurance Department (NHID) today announces the beginning of the 2025 Open Enrollment Period for the Affordable Care Act (ACA) Individual Marketplace. Open Enrollment starts Friday, November 1, 2024, and will run through Wednesday, January 15, 2025, allowing Granite Staters to secure health coverage for the upcoming year. For 2025, New Hampshire's Ave  more

WASHINGTON, Nov. 9 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release: U.S. Senator Maggie Hassan recognized Linda Sarette of Sanbornton as November's Granite Stater of the Month. Since 2019, Linda has dedicated herself to maintaining the gardens at the New Hampshire State Veterans Cemetery, ensuring this final resting place for fallen service members is a place of beauty and calm. Linda was first motivated to tend the cemetery gardens after her late father, who served i  more